Prostate Cancer - Results from #28540

Information for decision making by patients with early-stage prostate cancer: A comparison across 9 countries - Abstract March 2, 2011

Racial differences in well-being and cancer concerns in prostate cancer patients - Abstract March 2, 2011

Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer - Review of the literature - Abstract March 2, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Using Gleason pattern 5 to refine risk stratification for prostate cancer patients treated with dose-escalated radiotherapy and androgen deprivation therapy - Session Highlights March 2, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Role of traditional and modern hormone therapy for biochemical failures after local therapy - Session Highlights March 2, 2011

Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer - Abstract March 1, 2011

Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy - Abstract March 1, 2011

Association of obesity with prostate cancer: A case-control study within the population-based PSA testing phase of the ProtecT study - Abstract March 1, 2011

Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: A case-control study - Abstract March 1, 2011

ACR appropriateness criteria postradical prostatectomy irradiation in prostate cancer - Abstract March 1, 2011

Prostate cancer outcome and tissue levels of metal ions - Abstract March 1, 2011

Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer - Abstract March 1, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Overview of management of radiation failures in prostate cancer - Session Highlights March 1, 2011

Experience with sunitinib in hormone-resistant metastatic prostate cancer that is unresponsive to docetaxel - Abstract February 28, 2011

What do prostate cancer patients die of? - Abstract February 28, 2011

Assessment of aggressiveness of prostate cancer: Correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy - Abstract February 28, 2011

Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy - Abstract February 28, 2011

Disease-specific mortality may underestimate the total effect of prostate cancer screening - Abstract February 28, 2011

Using large institutional or national databases to evaluate prostate cancer outcomes and patterns of care: Possibilities and limitations - Abstract February 28, 2011

Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4) - Abstract February 28, 2011

Page 1428 of 1437